Alopecia Areata
Symptoms, Doctors, Treatments, Advances & More

Learn About Alopecia Areata

What is the definition of Alopecia Areata?

Alopecia areata is a common disorder that causes hair loss. "Alopecia" is a Latin term that means baldness, and "areata" refers to the patchy nature of the hair loss that is typically seen with this condition.

What are the causes of Alopecia Areata?

The causes of alopecia areata are complex and not well understood. A combination of factors likely underlies the disorder, including changes in many genes that function in the hair and skin and in the immune system.

How prevalent is Alopecia Areata?

Alopecia areata affects 1 in every 500 to 1,000 people in the United States. It is one of many recognized forms of alopecia; alopecia areata is the second most common form after androgenetic alopecia (male-pattern baldness in men and female-pattern baldness in women). Alopecia areata affects men and women equally, and it can occur in people of any ethnic background.

Is Alopecia Areata an inherited disorder?

The inheritance pattern of alopecia areata is unclear because multiple genetic and environmental factors appear to be involved. Overall, the risk of developing the condition is greater for first-degree relatives (such as siblings or children) of affected individuals than it is in the general population. People with alopecia areata are also more likely to have family members with other autoimmune disorders.

Who are the top Alopecia Areata Local Doctors?
Elite in Alopecia Areata
Pediatrics | Dermatology
Elite in Alopecia Areata
Pediatrics | Dermatology
Referral may be required

M Health Fairview Discovery Pediatric Specialty Clinic

2512 South 7th Street, Floor 3, 
Minneapolis, MN 
Languages Spoken:
English
Offers Telehealth

Maria Hordinsky is a Pediatrics specialist and a Dermatologist practicing medicine in Minneapolis, Minnesota. Dr. Hordinsky is rated as an Elite provider by MediFind in the treatment of Alopecia Areata. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Autosomal Recessive Hypotrichosis, Alopecia Areata, Graham-Little-Piccardi-Lassueur Syndrome, and Alopecia Universalis. Dr. Hordinsky is board certified in Dermatology: American Board Of Dermatology, 1980.

Elite in Alopecia Areata
Elite in Alopecia Areata
Referral required
1045 5th Street, 
Miami Beach, FL 
Languages Spoken:
English, Italian
Accepting New Patients
Offers Telehealth

Antonella Tosti is a Dermatologist practicing medicine in Miami Beach, Florida. Dr. Tosti is rated as an Elite provider by MediFind in the treatment of Alopecia Areata. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Autosomal Recessive Hypotrichosis, Alopecia Areata, Splinter Hemorrhages, and Ringworm. Dr. Tosti is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Alopecia Areata
Dermatology
Elite in Alopecia Areata
Dermatology
Referral may be required

Cleveland Clinic Main Campus

2049 East 100th Street, 
Cleveland, OH 
Experience:
66+ years
Languages Spoken:
English
Offers Telehealth

Wilma Bergfeld is a Dermatologist practicing medicine in Cleveland, Ohio. She has been practicing medicine for over 66 years. Dr. Bergfeld is rated as an Elite provider by MediFind in the treatment of Alopecia Areata. She is also highly rated in 74 other conditions, according to our data. Her clinical expertise encompasses Autosomal Recessive Hypotrichosis, Graham-Little-Piccardi-Lassueur Syndrome, Alopecia Areata, Squamous Cell Skin Carcinoma, and Osteotomy. Dr. Bergfeld is board certified in American Board Of Dermatology, 1974.

What are the latest Alopecia Areata Clinical Trials?
Dupilumab in the Treatment of Alopecia Areata Patients With an Atopic Background and/or High IgE

Summary: This is a prospective, randomized, double blind, placebo-controlled clinical trial. The study will take place at 4 sites. This trial will enroll a total of 68 patients with moderate to severe AA (affecting more than 50% of the scalp) at the time of screening with a targeted 54 subjects completers through Week 48. AA subjects must have evidence of hair regrowth within the last 7 years of their last...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3 Randomized, Placebo-controlled, Double-blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Severe Alopecia Areata

Summary: Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and face, but hair loss can happen on any part of the body. The purpose of this study is to assess how safe, effective, and tolerable upadacitinib is in adolescent and adult participants with severe AA. Upadacitinib is an approved drug being investigated fo...

Who are the sources who wrote this article ?

Published Date: June 01, 2018
Published By: National Institutes of Health